Clearing dead immune cells releases a signal that delays adaptive protection
After accelerated innate killing, clearance of dead phagocytes releases prostaglandin E2 that delays adaptive differentiation despite persistent antigen. Transfer of the delay through sterile culture medium, reversed by blocking the recipient receptor, would distinguish this mechanism.
Omega Point 1.2
Stage of verification
- Hypothesis published2026-09-21
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Receptor or channel
Prostaglandin E2 receptors
Receptors that receive prostaglandin E2 signals
Where this hypothesis actsIndependently primed recipient cultures exposed to medium collected during post-killing efferocytosis
Hypotheses on this target 1
Lower level
Higher level
Blockade1
Agonism
Desensitisation
Function restoration
Function preservation
What is proposed
Blockade
Selectively interrupt receptor signaling while maintaining pathogen killing
With whatNot stated in the record
HowReceptor perturbation with verified target engagement, without extending antigen display
Possible result
Possible removal of the transferred adaptive delay and restoration of functional response onset
From the recordSelectively interrupting recipient PGE2-receptor signaling removes that transfer and restores functional response onset without extending antigen display.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Killing an infection faster might leave the body's targeted defenses slower to become protective. The unexpected move is to blame the cleanup of dead immune cells: it could release a chemical signal that holds back those defenses even while recognizable pieces of the pathogen remain. This is a hypothesis generated by the pipeline, not a measured result.
- Faster pathogen killing is proposed to synchronize the subsequent controlled death of participating engulfing cells.
- Other cells clear those dead immune cells in a concentrated interval.
- That concentrated clearance is proposed to generate a brief rise in prostaglandin E2.
- The chemical signal is proposed to delay the development of targeted defenders while recognizable pathogen material remains available.
- Reducing the signal is predicted to restore timely protection while preserving pathogen killing; preserving recognizable material alone is predicted to fail.
A cleanup crew briefly sends out a stop-work message just as the next shift is getting started. Keeping the next shift's instructions on the noticeboard would not cancel that message.
Where the picture breaks: Immune cells do not receive a single uniform instruction, and the supplied literature includes settings where the proposed chemical messenger supports targeted defenses instead of suppressing them.
- Master questionstep 01 of 04
Durable immune restoration in older people would require both innate immunity, the body's rapid defenses, and adaptive immunity, its defenses directed at particular targets, to function within healthy young-adult ranges. It must also preserve immune memory, protection retained from earlier encounters; self-tolerance, restraint against attacking the body's own tissues; and control of latent infections, infections that persist without continuously causing active disease.
Rests on: The goal itself defines success as lasting restoration with all of these protections preserved together; it does not report that such restoration has been achieved.
Stated in the chain - Goal pillarstep 02 of 04
Recognition of a threat, presentation of recognizable pieces to immune cells, and the handoff to cells that carry out defense must resist failure.
Rests on: The master goal requires rapid and targeted defenses to function together while preserving protection.
Stated in the chain - Gap questionstep 03 of 04
Faster killing by rapid defenses might shorten the availability of antigen, material immune cells recognize, enough to delay targeted protection. Keeping that material available independently of living pathogens might prevent the delay without allowing surviving pathogens to escape.
Rests on: The preceding pillar identifies reliable handoffs as a concern but gives no account of how faster killing changes the time available for recognition.
LeapThe preceding text supplies neither the proposed shortening of antigen availability nor evidence that this shortening delays protection. The supplied sources do not establish that connection either.
- Hypothesisstep 04 of 04
Faster killing is proposed to synchronize apoptosis, a controlled process of cell death, in phagocytes, immune cells that engulf microbes and debris. Their efferocytosis, removal by other cells, is proposed to produce a brief rise in prostaglandin E2, a chemical messenger, that delays adaptive differentiation, the development of targeted immune cells into functional defenders, even while recognizable material remains.S2S4
Rests on: Nature Metabolism (2022, S2) reports that engulfing dying cells induces prostaglandin E2 production, and Cellular and Molecular Gastroenterology and Hepatology (2022, S4) also reports its production following this clearance. Neither establishes synchronized death after faster killing, a temporary suppressive signal during presentation, or delayed targeted protection despite retained antigen.
Supported by literature
What is carried, and what is not. Two screened sources, S2 and S4, support the clearance-to-prostaglandin E2 connection, which is part of one of the five mechanism links; neither establishes its proposed timing or the sequence end to end. International Journal of Molecular Sciences (2021, S5) reports that this messenger promotes development of particular targeted immune cells, and an Immunology and Cell Biology abstract (2016, S6) reports that it supports their activation and development; neither tests the proposed signal from dead-cell clearance, but both limit any assumption that its effect is necessarily suppressive.S2S4S5S6
Where the reasoning is carried by something unstated · 1
- Gap question. The preceding text supplies neither the proposed shortening of antigen availability nor evidence that this shortening delays protection. The supplied sources do not establish that connection either. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A delay transferred by conditioned medium, fluid collected from the source cultures, could be attributed to the proposed cleanup signal when it instead reflects surviving microbes, leftover killing reagents, different microbial ribonucleic acid signals, or damage to recipient cells. What closes it: The specification requires verifying that the fluid contains no living microbes and excluding residual killing reagents, differences in microbial ribonucleic acid, the proposed microbial instruction signal, and toxicity to recipient cells. Those exclusions must accompany the transfer result.
- An apparent rescue after blocking the recipient receptor, the cell component that detects the messenger, could be mistaken for removal of transferred suppression even if blocking it changes the recipient response independently. What closes it: Compare receptor interruption with and without transferred cleanup fluid and verify that the interruption actually blocks the intended signal. Match the time course of displayed antigen fragments, microbial instruction signals, and contacts between displaying cells and responding cells, as the prediction requires.
- Earlier functional responses in recipient cultures could be read as proof that the intervention preserves pathogen killing, although the transfer test separates recipients from the original killing process. What closes it: Pathogen killing and surviving pathogen burden must also be measured where the suppressive pathway is reduced. Rescue in recipient cultures alone does not establish this required part of the hypothesis.
What would make this wrong. The specification identifies two rejecting observations: accelerated killing does not increase dead-cell clearance and prostaglandin E2, or interrupting the proposed signaling pathway fails to restore timely functional responses despite verified blockade. The latter comparison requires matched antigen display, microbial instruction signals, and relevant cell-contact schedules so that a rival cause of delay does not obscure the result.
What it would change. If the hypothesis held, restoring rapid killing would also require attention to signals produced during cleanup: preserving recognizable pathogen material alone could leave targeted protection delayed. Work toward the master goal would have to distinguish inadequate recognition time from active suppression after killing. Even a successful culture test would not establish durable restoration in older people, preservation of immune memory and self-tolerance, or control of latent infections.
Sources read · 9
Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging. · Science (New York, N.Y.) · 2026
“Pharmacologic EP2 inhibition restored youthful neutrophil clearance, establishing impaired TRM efferocytosis as a reversible driver of organ decline in aging.”
Does not settle: It does not establish that corpse clearance generates a transient PGE2 pulse, suppresses adaptive differentiation during antigen presentation, or that reducing such a pulse preserves pathogen killing while reversing delayed adaptive protection.
Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution. · Nature metabolism · 2022
“Here, we show that AC-derived methionine regulates resolution through epigenetic repression of the ERK1/2 phosphatase Dusp4. We focus on two key efferocytosis-induced pro-resolving mediators, PGE2 and TGFβ1, and show that efferocytosis induces Ptgs2/COX2, leading to PGE2 synthesis and PGE2-mediated induction of TGFβ1.”
Does not settle: This source does not establish suppression of adaptive differentiation during antigen presentation, a delay in adaptive protection, preservation of usable antigen, pathogen killing, or that reducing the PGE2 pulse reverses such an effect while maintaining killing.
Extracellular vesicles from human plasma dampen inflammation and promote tissue repair functions in macrophages. · Journal of extracellular vesicles · 2023
“although we found that pEVs mediate the induction of PGE2 production by macrophages. This prostaglandin is, in turn, critical for the anti‐inflammatory activity of pEVs.”
Does not settle: This source does not establish that apoptotic-cell clearance generates the PGE2 pulse, that phagocyte apoptosis or efferocytosis synchronizes it, or that it suppresses adaptive differentiation during antigen presentation while antigen persists.
Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair. · Cellular and molecular gastroenterology and hepatology · 2022
“apMPRO cell efferocytosis induced, in a COX2-dependent manner, PGE2, PGI2 (as measured by 6ketoPGF1α), and LXA4”
Does not settle: The source does not establish delayed or suppressed adaptive differentiation during antigen presentation, accelerated innate execution or synchronized phagocyte apoptosis, persistence of usable antigen, or that reducing a PGE2 pulse preserves pathogen killing and prevents reversal.
Mycobacterium tuberculosis RpfE-Induced Prostaglandin E2 in Dendritic Cells Induces Th1/Th17 Cell Differentiation. · International journal of molecular sciences · 2021
“Here, we show that PGE2 produced by RpfE-activated DCs via the MAPK and cyclooxygenase 2 signaling pathways induces Th1 and Th17 cell responses mainly via the EP4 receptor.”
Does not settle: This source does not test PGE2 generated by apoptotic-phagocyte efferocytosis, a transient suppressive presentation-window signal, antigen preservation, accelerated innate execution, or whether reducing PGE2 maintains pathogen killing while preventing reversal.
Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors. · Immunology and cell biology · 2016
“autocrine PGE2 signaling through EP receptors is essential for optimal CD4(+) T-cell activation in vitro and in vivo, and for T helper 1 (Th1) and regulatory T cell differentiation.”
Does not settle: This abstract does not address dead immune-cell clearance, phagocyte apoptosis or efferocytosis, a transient corpse-clearance-derived PGE2 pulse, antigen persistence, pathogen killing, or suppression during a presentation window. It reports PGE2 signaling as supportive of T-cell activation and differentiation in the described settings.
Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. · Blood · 2004
“CsA impairs chemokine receptor and cyclooxygenase-2 (COX-2) expression normally triggered in LPS-stimulated DCs; administration of exogenous prostaglandin E2 (PGE2) reverses the effects of CsA on chemokine receptor expression and DC migration.”
Does not settle: This abstract does not assess apoptotic phagocytes, efferocytic corpse clearance, a transient PGE2 pulse, antigen persistence, pathogen killing, or suppression of adaptive differentiation during antigen presentation.
Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities. · Investigative ophthalmology & visual science · 2014
“Topical COX-2/EP2 treatment reduces CCR7+CD11b+ cells on the ocular surface with inhibition of cellular LN homing and suppresses Th17 immune response”
Does not settle: This mouse dry-eye study does not establish whether corpse clearance generates a transient PGE2 suppressive pulse, whether antigen persists during presentation, or whether reducing such a pulse preserves pathogen killing and reverses delayed adaptive protection.
The impact of trauma relevant concentrations of prostaglandin E2 on the anti-microbial activity of the innate immune system. · Frontiers in immunology · 2024
“MDMs pre-treated with PGE 2 secreted significantly lower amounts of TNF-α following LPS stimulation”
Does not settle: This source does not establish that corpse clearance generates a transient PGE2 pulse, that this pulse follows phagocyte apoptosis or efferocytosis, or that it suppresses adaptive differentiation during antigen presentation while antigen persists.
The gap this hypothesis explains
Can faster early pathogen killing delay learned immune protection, and can preserving recognizable pathogen material prevent this without infectious escape?
Original wording · exactly as the pipeline generated it
Can accelerating innate killing shorten antigen availability enough to delay adaptive protection, and does independently preserving presentable antigen prevent this reversal without permitting viable-pathogen escape?
What this question is asking
The question asks whether making the body's early immune response kill disease-causing organisms faster could slow the development of its learned protection. It asks whether faster killing removes recognizable pathogen material, called antigen, so quickly that the adaptive immune response has insufficient opportunity to develop protection. It then asks whether keeping antigen available for immune cells to display, independently of keeping pathogens alive, prevents that delay without allowing living pathogens to survive and evade control. The comparison is faster killing alone versus faster killing with preserved antigen, judged by the time needed for adaptive protection and whether living pathogens escape control. The broader motivation is restoring immune function in older people while retaining immune memory, avoiding attacks on the body's own tissues, and maintaining control of persistent infections; the supplied source does not establish those outcomes.
- Pathogen
- A disease-causing organism or infectious agent. The question does not specify which pathogen is involved.
- Innate immunity and innate killing
- Innate immunity is the body's early defense system; innate killing means its destruction of pathogens. Accelerating that killing is the proposed change, but the supplied material specifies no intervention that produces it.
- Adaptive immunity and adaptive protection
- Adaptive immunity is the learned, targeted part of immune defense. Adaptive protection here means its ability to protect against the pathogen; the supplied material does not define how that protection would be measured.
- Antigen and antigen availability
- Antigen is material recognized by the immune system. Availability refers here to how long that material remains accessible for recognition, rather than simply whether a pathogen is still alive.
- Presentable antigen and antigen presentation
- Presentable antigen is material that immune cells can display for recognition by other immune cells. Antigen presentation is that display process; preserving presentable material is not the same outcome as preserving living pathogens.
- Independent antigen preservation
- The proposed maintenance of presentable pathogen material separately from the survival of living pathogens. The supplied material does not specify a preservation method or establish that this separation succeeds.
- Viable-pathogen escape
- Survival and escape from control by pathogens that remain capable of sustaining infection. The question specifies no particular route of escape.
- Age-related immune dysfunction
- Immune functions that become impaired with age. This is the broader target of the question, but the supplied material gives no criteria for impairment or successful restoration.
- Immune memory
- Retention of learned immune recognition after an earlier encounter. Preserving protective memory is one constraint in the broader restoration goal.
- Self-tolerance
- Immune restraint toward the body's own tissues. The broader goal requires restored defense without losing that restraint.
- Latent infection
- An infection that persists in a relatively inactive state. Maintaining control of such infections is part of the broader goal, but is not examined by the supplied source.
- T cells and T cell activation
- T cells are immune cells involved in targeted immune responses; activation is their engagement in a response. S1 discusses activation in connection with attack on muscle, not demonstrated protection from infection.
- Inclusion body myositis
- The muscle disease examined in S1. The supplied abstract discusses immune attack on muscle in this setting, which differs from the pathogen-control setting of the question.
- Faster killing does not delay protection If faster killing does not shorten antigen availability enough to delay learned protection, the proposed reversal does not occur. Preserving antigen would then have no demonstrated delay to prevent under those conditions.
- Antigen preservation prevents delay without escape If faster killing reduces antigen availability and delays learned protection, preserving material that immune cells can display could prevent that delay. If living pathogens remain controlled, recognizable material and infectious survival would be separable in the way the question asks.
- Antigen preservation does not prevent delay If protection remains delayed despite preserving presentable antigen, preservation alone would not resolve the reversal. Faster early killing would still carry the observed timing cost under those conditions.
- Delay is prevented, but living pathogens escape If antigen preservation prevents the delay but living pathogens escape control, the combined outcome sought by the question is not achieved. Timely learned protection would coexist with failure to contain the infection.
The proposed chain starts with faster early killing, followed by a shorter supply of recognizable pathogen material, followed by delayed learned protection. If that chain occurs, an improvement in early pathogen removal could come with a later protection cost. If preserved antigen prevents the delay while living pathogens remain controlled, the proposed tradeoff could be avoided. Treating this possibility as established could wrongly equate longer antigen availability with better protection: the supplied source instead discusses sustained antigen presentation in an immune attack on muscle [S1].
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Accelerated innate execution synchronizes the subsequent apoptosis of participating phagocytes and their efferocytic removal. The resulting prostaglandin E2 pulse suppresses adaptive differentiation during the presentation window even when usable antigen persists. The causal substrate is a transient soluble suppressive signal generated by corpse clearance. Preserving antigen alone cannot prevent the reversal; reducing the suppressive pulse while maintaining pathogen killing can.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
At matched peptide–MHC trajectories, microbial-RNA instruction and cognate-contact schedules, sterile conditioned medium collected during post-killing efferocytosis transfers the adaptive delay to independently primed cultures. Selectively interrupting recipient PGE2-receptor signaling removes that transfer and restores functional response onset without extending antigen display. Absence of increased efferocytosis/PGE2 after accelerated killing, or failure of pathway interruption to rescue despite verified target engagement, rejects the hypothesis.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable transfer of response delay, its removal by pathway interruption, and explicit rejection conditions. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Live imaging, lipid measurements, conditioned-medium transfer and receptor perturbation can separate the proposed suppressive signal from antigen loss. Verify sterility and exclude residual killing reagents, RNA differences and cytotoxicity as explanations for medium-transfer effects.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
At matched peptide–MHC trajectories, microbial-RNA instruction and cognate-contact schedules, sterile conditioned medium collected during post-killing efferocytosis transfers the adaptive delay to independently primed cultures. Selectively interrupting recipient PGE2-receptor signaling removes that transfer and restores functional response onset without extending antigen display. Absence of increased efferocytosis/PGE2 after accelerated killing, or failure of pathway interruption to rescue despite verified target engagement, rejects the hypothesis.
- Rival 01 of 02What would separate them
Bacterial signals can sustain immune protection after further antigen recognition stops predicts: In older-donor cultures, first document cognate priming and matched T–B interaction, then terminate further antigen-receptor signaling using independently validated interventions. Non-antigen-encoding bacterial RNA delivered selectively to APCs restores the onset of antigen-specific target killing and functional antibody production despite absent subsequent cognate signaling. Matched antigen extension without RNA-dependent instruction does not restore both deadlines. Rescue confined to CD8 proliferation, nonspecific cytokine release or pre-existing antibody secretion falsifies the strong hypothesis.
- Rival 02 of 02What would separate them
Rapid killing delays immune protection when cells cannot meet before antigen display ends predicts: With peptide identity, display amplitude, APC instruction and cell numbers matched, long or variable waits predict missed functional-response deadlines after rapid killing. Bringing cognate responders into contact earlier rescues cellular and humoral onset without antigen supplementation. Extending display preferentially recruits previously unprimed responders rather than accelerating differentiation of responders already primed. Failure of measured contact completion to predict rescue, together with rescue by RNA instruction or suppressor blockade at unchanged contact schedules, rejects this explanation.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 7 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma.; Neuroinflammation in Central Nervous System Tumors.; Human Group IIA Secreted Phospholipase A<sub>2</sub> and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms..
7 papers retrieved around this hypothesis
- PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma.PMID 42586608 · full_text · 72,954 characters stored
- Neuroinflammation in Central Nervous System Tumors.PMID 42738905 · full_text · 111,232 characters stored
- Human Group IIA Secreted Phospholipase A<sub>2</sub> and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms.PMID 42653281 · full_text · 134,378 characters stored
- Homeostatic Regulation of Lung Dendritic Cells at Steady State.PMID 42694093 · full_text · 77,065 characters stored
- Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.PMID 42459678 · full_text · 106,705 characters stored
- Immune Escape in Renal Cell Carcinoma: Latest Research and Treatment Strategies.PMID 41977251 · full_text · 78,338 characters stored
- Spatial-Bioenergetic-Immune Axis in Type 2 Diabetes Mellitus-Associated Sarcopenia: A Review from Pathogenesis to Targeted Reconstruction.PMID 42676423 · full_text · 129,605 characters stored
0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.